Avaleht › Haavandiline koliit › Louisiana
Haavandiline koliit kliinilised uuringud osariigis Louisiana
15 uuringut haiguse Haavandiline koliit jaoks otsivad osalejaid osariigis Louisiana.
Linnad osariigis Louisiana
- Metairie8 uuringut
- New Orleans6 uuringut
- Lafayette5 uuringut
- Baton Rouge4 uuringut
- Monroe3 uuringut
- Shreveport3 uuringut
Ametlik uuringutekst (inglise keeles)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Gastro Group and Endocenter: Mandeville, la /ID# 284186, Mandeville
- Metropolitan Gastroenterology Associates - Metairie /ID# 283922, Metairie
- Willis-Knighton Medical Center /ID# 280572, Shreveport
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 2. okt 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Baton Rouge General Medical Center - Bluebonnet Campus, Baton Rouge
- Combined Gastro LLC, Lafayette
- GI Alliance, Metairie
VärbamineFaas 4
Vanused 18–80 · Kõik sood · Uuendatud 30. sept 2026 · NCT06581328A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Clinical Trials Management, LLC, Metairie
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 30. sept 2026 · NCT06598943A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 035, Marrero
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 29. sept 2026 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-008, Baton Rouge
- Site US-011, Mandeville
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 29. sept 2026 · NCT07845487A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
- Tulane University School of Medicine-Gastroenterology and Hepatology ( Site 1073), New Orleans
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 28. sept 2026 · NCT07463183A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- Delta Research Partners, LLC, West Monroe
VärbamineFaas 3
Vanused 12 ja vanemad · Kõik sood · Uuendatud 25. sept 2026 · NCT07196748Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Care Access - New Iberia, New Iberia
- Louisiana Research Center, Shreveport
VärbamineFaas 3
Vanused 18–70 · Kõik sood · Uuendatud 24. sept 2026 · NCT06937086LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- GI Alliance - Gastro Group and Endocenter - Mandeville, Mandeville
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 22. sept 2026 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- GI Alliance, Metairie
- Tulane University, New Orleans
VärbamineFaas 4
Vanused 18–65 · Kõik sood · Uuendatud 21. sept 2026 · NCT06095128A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- GI Alliance - Baton Rouge - Site Number: 8400129, Baton Rouge
- Texas Digestive Disease Consultants, PLLC d/b/a GI Alliance - Mandeville - Site Number: 8400128, Mandeville
- Delta Research Partners - Site Number: 8400087, Monroe
VärbamineFaas 3
Vanused 16–80 · Kõik sood · Uuendatud 15. sept 2026 · NCT07185009A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Clinic of Acadiana, Lafayette
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. aug 2026 · NCT07577856An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- GI Alliance - Baton Rouge - Site Number: 8400129, Baton Rouge
- Tandem Intermediate, LLC - Houma -Site Number: 8400034, Houma
- GastroGroup - Site Number: 8400128, Mandeville
- ja veel 4
VärbamineFaas 3
Vanused 16–80 · Kõik sood · Uuendatud 20. aug 2026 · NCT07184996A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Lafayette
- Mirador Therapeutics Selected Site, Marrero
- Mirador Therapeutics Selected Site, Shreveport
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 12. märts 2026 · NCT07113522Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
- Tulane University, New Orleans
VärbamineVaatlusuuring
Vanused 18 ja vanemad · Kõik sood · Uuendatud 8. mai 2025 · NCT06750731Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.